Keywords: Takeda, Half-year financial results, Full-year forecasts

Takeda slashes full-year forecasts on Nycomed costs and yen strength

Article | 07 November 2011

Takeda Pharmaceuticals (TYO: 4502), Japan’s largest drugmaker, posted flat results for the fiscal half year ended September 30, 2011, but also ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Takeda Pharmaceuticals

Go to company listing